Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,082 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of Implementation Strategies for Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), and Mindfulness-Based Stress Reduction (MBSR): a Systematic Review.
Goldsmith ES, Koffel E, Ackland PE, Hill J, Landsteiner A, Miller W, Stroebel B, Ullman K, Wilt TJ, Duan-Porter WD. Goldsmith ES, et al. Among authors: miller w. J Gen Intern Med. 2023 Sep;38(12):2782-2791. doi: 10.1007/s11606-023-08140-4. Epub 2023 Apr 3. J Gen Intern Med. 2023. PMID: 37012538 Free article.
Costs of implementing a multi-site facilitation intervention to increase access to medication treatment for opioid use disorder.
Garcia CC, Bounthavong M, Gordon AJ, Gustavson AM, Kenny ME, Miller W, Esmaeili A, Ackland PE, Clothier BA, Bangerter A, Noorbaloochi S, Harris AHS, Hagedorn HJ. Garcia CC, et al. Among authors: miller w. Implement Sci Commun. 2023 Aug 10;4(1):91. doi: 10.1186/s43058-023-00482-8. Implement Sci Commun. 2023. PMID: 37563672 Free PMC article.
Co-occurring implementation strategies: The effects of academic detailing for opioid use disorder campaign on the advancing pharmacological treatments for opioid use disorder (ADaPT-OUD) study.
Miller WA, Gordon AJ, Clothier BA, Ackland PE, Bounthavong M, Garcia C, Kenny ME, Noorbaloochi S, Hagedorn HJ. Miller WA, et al. Implement Res Pract. 2023 Sep 14;4:26334895231199463. doi: 10.1177/26334895231199463. eCollection 2023 Jan-Dec. Implement Res Pract. 2023. PMID: 37790176 Free PMC article.
ADAR Family Proteins: A Structural Review.
Ashley CN, Broni E, Miller WA 3rd. Ashley CN, et al. Among authors: miller wa 3rd. Curr Issues Mol Biol. 2024 Apr 26;46(5):3919-3945. doi: 10.3390/cimb46050243. Curr Issues Mol Biol. 2024. PMID: 38785511 Review.
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
Armstrong AJ, Geva R, Chung HC, Lemech C, Miller WH Jr, Hansen AR, Lee JS, Tsai F, Solomon BJ, Kim TM, Rolfo C, Giranda V, Ren Y, Liu F, Kandala B, Freshwater T, Wang JS. Armstrong AJ, et al. Among authors: miller wh jr. Invest New Drugs. 2024 May 20. doi: 10.1007/s10637-024-01444-0. Online ahead of print. Invest New Drugs. 2024. PMID: 38767685 No abstract available.
Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM.
Pack AM, Oskoui M, Williams Roberson S, Donley DK, French J, Gerard EE, Gloss D, Miller WR, Munger Clary HM, Osmundson SS, McFadden B, Parratt K, Pennell PB, Saade G, Smith DB, Sullivan K, Thomas SV, Tomson T, Dolan O'Brien M, Botchway-Doe K, Silsbee HM, Keezer MR. Pack AM, et al. Among authors: miller wr. Neurology. 2024 Jun;102(11):e209279. doi: 10.1212/WNL.0000000000209279. Epub 2024 May 15. Neurology. 2024. PMID: 38748979
6,082 results